Inhibitory activity of acetylcholinesterase by 18 extracts Guatemala native plant species used in the treatment of nervous disorders

Authors

  • Dayrin Ortiz Escuela de Química Biológica, Facultad de Ciencias Químicas y Farmacia. USAC
  • Ana Valdez Escuela de Química Biológica, Facultad de Ciencias Químicas y Farmacia. USAC
  • Armando Cáceres Escuela de Química Biológica, Facultad de Ciencias Químicas y Farmacia. USAC

Keywords:

Lantana camara, Tagetes lucida, Valeriana prionophylla, Wigandia urens var. caracasana, Lippia graveolens, Chaptalia mutans

Abstract

Abstract

Neurodegenerative syndromes generate memory and behavior deterioration, usually in the elderly.The most common is Alzheimer´s disease, which is associated with decreased levels of acetylcholine(ACh) after an increase of acetylcholinesterase (AChE). Worldwide studies have described somesecondary metabolites from plants that might inhibit the enzyme activity or retard neuronal deterioration.With the aim of finding inhibitors of AChE, activity was evaluated in extracts (dichloromethane andmethanol) of 18 medicinal and aromatic plants used in Guatemala for nervous or memory disorders(Brugmansia candida, Cassia reticulata, Chaptalia nutans, Chiranthodendron pentadactylon, Dorsteniacontrajerva, Erythrina berteroana, Lantana camara, Lippia graveolens, Petiveria alliacea, Phlebodiumpseudoaureum, Pimenta dioica, Salvia microphylla, Solanum nigrescens, Tagetes lucida, Ternstroemiatepezapote, Valeriana prionophylla, Vernonia deppeana and Wigandia urens var. caracasana). AChEinhibition was assessed qualitatively by two bioautographic TLC assays and quantitatively by akinetic microcolorimetric evaluation. The results demonstrated activity by bioautography in all speciesat screening concentration (5 μl), but when quantified by microcolorimetry no significant activity(>50%) was demonstrated at 1 mg/mL. Three of the species with shown activity (L. camara, T. lucidaand V. prionophylla) were partitioned to see if the liquid:liquid partions presented more activity, butthis did not increase the activity. Intermediate activity was also found in extracts from C. nutans, D.contrajerva var. houstoni, L. graveolens and W. urens var. caracasana. Studies will continue regardingthe antioxidant activity in order to determine whether there might be some potential use.

Keywords:

Lantana camara, Tagetes lucida, Valeriana prionophylla, Wigandia urens var. caracasana,Lippia graveolens, Chaptalia nutans.

References

Referencias

Adams, M., Gmünder, F. & Hamburger, M.

(2007). Plants traditionally used in age

related brain disorders - A survey of

ethnobotanical literature. Journal of

Ethnopharmacology, 111, 363-381.

Adsersen, A., Gaugin, B., Gudiksen, L. & Jäger,

A.K. (2006). Screening of plants used in

Danish folk medicine to treat memory

dysfunction for acetylcholinesterase

inhibitory activity. Journal of

Ethnopharmacology, 104, 418-422.

Akhondzadeh, S. & Abassi, S.H. (2006). Herbal

medicine in the treatment of Alzheimer’s

disease. American Journal of Alzheimer’s

Disease and Other Dementias, 21, 113-

Barbosa Filho, J.M., Medeiros, K.C.P., Diniz,

M.F.F.M., Batista, L.M., Athayde-Filho,

P.F., Silva, M.S. et al. (2006). Natural

products inhibitors of the enzyme

acetycholinesterase. Brazilian Journal of

Pharmacognosy 16, 258-285.

Calderón. A.I., Cubilla, M., Espinosa, A. &

Gupta, M.P. (2010). Screening of plants

of Amaryllidaceae and related families

from Panama as sources of

acetylcholinesterase inhibitors.

Pharmaceutical Biology. 48, 988-

Carpinella, M.C., Andrione, D.G., Ruiz, G. &

Palacios, S.M. (2010). Screening for

acetylcholinesterase inhibitory activity in

plant extracts from Argentina.

Phytotherapy Research, 24, 259-263.

Chopra, K., Misra, B. & Kuhad, A. (2011).

Current perspectives on pharmacotherapy

of Alzheimer’s disease. Expert Opinion

in Pharmacotherapy, 12, 335-350.

Ellman, G.L., Courtney, K.D., Andres, V. &

Featherstone, R.M. (1961). A new and

rapid colorimetric determination of

acetylcholinesterase activity. Biochemistry

Pharmacology, 7, 88-95

Figueiró, M., Ilha, J., Pochmann, D., Porciúncula,

L.O., Xavier, L.L., Achaval, M. et al.

(2010). Acetylcholinesterase inhibition in

cognition-relevant brain areas of mice

treated with a nootropic Amazonian herbal

(Marapuama). Phytomedicine. 17, 956-

Houghton, P.J., Ren, Y. & Howes, M.J. (2006).

Acetylcholinesterase inhibitors from plants

and fungi. Natural Products Report, 23,

-199.

Howes, M.J. & Perry, E. (2011). The role of

phytochemicals in the treatment and

prevention of dementia. Drugs Aging, 28,

-468.

Kalaria, R.J., Maestre, G.E., Arizaga, R.,

Friedland, R.F., Galasko, D., Hall, K. et

al. (2008). Alzheimer’s disease and

vascular dementia in developing countries:

prevalence, management, and risk factors.

Lancet Neurology, 7, 812-826.

Kim, J., Lee, H.J. & Lee, K.W. (2010). Naturally

occurring phytochemicals for the

prevention of Alzheimer’s disease. Journal

of Neurochememistry, 112, 1415-1430.

Marco, L. & Carreiras, C.C. (2006).

Galanthamine, a natural product for the

treatment of Alzheimer’s disease. Recent

Patents in CNS Drug Discovery, 1, 105-

Marston, A., Kissling, I. & Hostettmann, K.

(2002). A rapid TLC bioautography

method for the detection of

a c e t y l c h o l i n e s t e r a s e a n d

butyrylcholinesterase inhibitors in plants.

Phytochemistry Analysis, 13, 51-54.

Mosquera, O.M., Niño, J., Correa, Y.M. &

Hernández, J.A. (2004). Detección in vitro

de inhibidores de la acetilcolinesterasa en

extractos de cuarenta plantas de la flora

colombiana mediante el método

cromatográfico de Ellman. Scientia et

Technica, 10, 155-160.

Peng, S. & Zhao, M. (2009). Pharmaceutical

Bioassays. Methods and Applications.

Hoboken, NJ:John Wiley & Sons, Inc..

p (pp. 129).993.

Perry, E. & Howes, M.J.R. (2010). Medicinal

plants and dementia therapy: Herbal hopes

for brain aging? CNS Neuroscience

Therapy, 17, 1-16

Rubinsztein, D.C. (2006). The roles of

intracellular protein-degradation pathways

in neurodegeneration. Nature, 443,

–786.

Siqueira, I.R., Fochesatto, C., da Silva, A.L.,

Nunes, D.S., Battastini, A.M., Netto, C.A.

& Elisabetsky, E. (2003). Ptychopetalum

olacoides, a traditional Amazonian “nerve

tonicâ€, possess anticholinesterase activity.

Pharmacology, Biochemistry & Behavior,

, 645-650.

Vinutha, B., Prashanth, D., Salma, K., Sreeja,

S.L., Pratti, D., Padmaja, R. et al. (2007).

Screening of selected Indian medicinal

plants for acetylcholinesterase inhibitory

activity. Journal of Ethnopharmacology,

, 359-363.

Yang, Z., Zhang, X., Duan, D., Song, Z., Yang,

M. & Li, S. (2009). Modified TLC

bioautographic method for screening

acetylcholinesterase inhibitors from plant

extracts. Journal of Separation Science.

, 3257-3259.

Wilkinson, D. (2007). Pharmacotherapy of

Alzheimer’s disease. Psychiatry, 7, 9-14.

Downloads

Published

2013-05-31

Issue

Section

Artículos